Terms: = Colorectal cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088
17 results:
1. Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
Nader-Marta G; Singer C; Hlauschek D; DeMichele A; Tarantino P; de Azambuja E; Pfeiler G; Martin M; Balko JM; Nowecki Z; Balic M; Brufsky AM; Chan A; Morris PG; Haddad T; Loibl S; Liu Y; Soelkner L; Fesl C; Mayer EL; Gnant M;
Breast Cancer Res; 2024 Oct; 26(1):140. PubMed ID: 39375745
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
3. Prospective Series of Transarterial Chemoembolization of Metastatic colorectal cancer to the Liver with 30-60 μm Microspheres Loaded with Irinotecan.
Malagari K; Kiakidis T; Moschouris H; Charokopakis A; Vergadis C; Alevisopoulos N; Kartsouni V; Panagiotou I; Pellerin O; Glantzounis G; Filippiadis DK; Emmanouil E; Tsavaris N; Psarros G; Delicha E; Kelekis N
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):880-890. PubMed ID: 37337059
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological targeting ptk6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
[TBL] [Abstract] [Full Text] [Related]
5. Adenocarcinoma at the Ileostomy Site After a Proctocolectomy for Ulcerative Colitis and/or Familial Adenomatous Polyposis: An Overview.
James SD; Hawkins AT; M'Koma AE
Ostomy Wound Manage; 2018 Jun; 64(6):30-40. PubMed ID: 30059346
[TBL] [Abstract] [Full Text] [Related]
6. Murine MTHFD1-synthetase deficiency, a model for the human MTHFD1 R653Q polymorphism, decreases growth of colorectal tumors.
Lévesque N; Christensen KE; Van Der Kraak L; Best AF; Deng L; Caldwell D; MacFarlane AJ; Beauchemin N; Rozen R
Mol Carcinog; 2017 Mar; 56(3):1030-1040. PubMed ID: 27597531
[TBL] [Abstract] [Full Text] [Related]
7. Kinase-Dependent and -Independent Roles for ptk6 in Colon cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
Zhang F; Luo Y; Shao Z; Xu L; Liu X; Niu Y; Shi J; Sun X; Liu Y; Ding Y; Zhao L
Cancer Lett; 2016 Apr; 373(2):203-13. PubMed ID: 26820227
[TBL] [Abstract] [Full Text] [Related]
9. HIF-1α-independent hypoxia-induced rapid ptk6 stabilization is associated with increased motility and invasion.
Pires IM; Blokland NJ; Broos AW; Poujade FA; Senra JM; Eccles SA; Span PN; Harvey AJ; Hammond EM
Cancer Biol Ther; 2014 Oct; 15(10):1350-7. PubMed ID: 25019382
[TBL] [Abstract] [Full Text] [Related]
10. Surgical site infections following short-term radiotherapy and total mesorectal excision: results of a randomized study examining the role of gentamicin collagen implant in rectal cancer surgery.
Rutkowski A; Zając L; Pietrzak L; Bednarczyk M; Byszek A; Oledzki J; Olesiński T; Szpakowski M; Saramak P; Chwalinski M
Tech Coloproctol; 2014 Oct; 18(10):921-8. PubMed ID: 24993838
[TBL] [Abstract] [Full Text] [Related]
11. Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.
Gierut JJ; Mathur PS; Bie W; Han J; Tyner AL
Mol Cancer Ther; 2012 Nov; 11(11):2311-20. PubMed ID: 22989419
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
Xie T; D' Ario G; Lamb JR; Martin E; Wang K; Tejpar S; Delorenzi M; Bosman FT; Roth AD; Yan P; Bougel S; Di Narzo AF; Popovici V; Budinská E; Mao M; Weinrich SL; Rejto PA; Hodgson JG
PLoS One; 2012; 7(7):e42001. PubMed ID: 22860045
[TBL] [Abstract] [Full Text] [Related]
13. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
[TBL] [Abstract] [Full Text] [Related]
14. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances ptk6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract] [Full Text] [Related]
15. Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.
Chen WS; Kung HJ; Yang WK; Lin Wc
Int J Cancer; 1999 Nov; 83(5):579-84. PubMed ID: 10521789
[TBL] [Abstract] [Full Text] [Related]
16. brk/Sik expression in the gastrointestinal tract and in colon tumors.
Llor X; Serfas MS; Bie W; Vasioukhin V; Polonskaia M; Derry J; Abbott CM; Tyner AL
Clin Cancer Res; 1999 Jul; 5(7):1767-77. PubMed ID: 10430081
[TBL] [Abstract] [Full Text] [Related]
17. The distribution of brk alpha/RbK alpha peak intensity ratio in human whole blood samples. Comparison between normal and colorectal cancer cases.
Shenberg C; Spiegel S; Chaitchik S; Jordan P; Kitzis M; Altman M; Cohen Y; Boazi M
Biol Trace Elem Res; 1994 Sep; 42(3):231-41. PubMed ID: 7826816
[TBL] [Abstract] [Full Text] [Related]
